Viewing Study NCT05806359


Ignite Creation Date: 2025-12-24 @ 2:31 PM
Ignite Modification Date: 2026-03-01 @ 4:12 PM
Study NCT ID: NCT05806359
Status: COMPLETED
Last Update Posted: 2024-05-23
First Post: 2023-03-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Participants
Sponsor: Bristol-Myers Squibb
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-03-31
Start Date Type: ACTUAL
Primary Completion Date: 2023-08-14
Primary Completion Date Type: ACTUAL
Completion Date: 2023-08-14
Completion Date Type: ACTUAL
First Submit Date: 2023-03-29
First Submit QC Date: None
Study First Post Date: 2023-04-10
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-21
Last Update Post Date: 2024-05-23
Last Update Post Date Type: ACTUAL